Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while revenue slightly missed estimates.

Relmada, which has turned to strategic options after scrapping two phase 3 trials in major depressive disorder (MDD), is ...

The Company has also granted to the underwriter a 30-day option to purchase up to an additional 1,200,000 shares of common stock at the public offering price per share, less underwriter discounts and ...

Harvard researchers have found that M. morganii may contribute to depression by producing an inflammatory molecule.

A new study reveals that heavy drinkers with depression experience the same level of buzz as those without depression, challenging the long-standing belief that alcohol's pleasurable effects diminish ...

It's no secret that there is a mental health crisis in the United States. As of 2021, 8.3% adults had major depressive disorder (MDD) and 19.1% had anxiety disorders (AD), and the COVID-19 pandemic ...

Researchers develop machine learning tools that screen for co-morbid anxiety disorders and major depressive disorder using acoustic voice signals. The team spoke to participants with and without ...

Researchers have developed an automated screening tool that can reliably diagnose mental health issues using voice analysis.

While there are many treatment options for depression, natural remedies, self-care methods, and alternative therapies can ...

It's no secret that there is a mental health crisis in the United States. As of 2021, 8.3% of adults had major depressive disorder (MDD) and 19.1% had anxiety disorders (AD), and the COVID-19 pandemic ...

Virtual reality meditation effectively reduces depression and anxiety symptoms while improving emotional regulation in ...

A new study from the University of Chicago Medicine reveals that people with alcohol use disorder (AUD) and depression experience high levels of stimulation and pleasure when intoxicated, similar to ...